T1	Limited_variation	32 54	wild-type for EGFR and
T2	Limited_variation	55 70	KRAS regardless
T3	Pharmacodynamic_phenotype	74 97	erlotinib sensitivity ;
T4	Pharmacodynamic_phenotype	110 145	erlotinib -resistant cell line ( HN
T5	Limited_variation	167 182	G12D mutation .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	influences	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	influences	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T2
R10	isAssociatedWith	Arg1:T3	Arg2:T5
R11	isAssociatedWith	Arg1:T4	Arg2:T1
R12	isAssociatedWith	Arg1:T4	Arg2:T2
R13	influences	Arg1:T4	Arg2:T3
R14	isAssociatedWith	Arg1:T4	Arg2:T5
R15	isAssociatedWith	Arg1:T5	Arg2:T1
R16	isAssociatedWith	Arg1:T5	Arg2:T2
R17	isAssociatedWith	Arg1:T5	Arg2:T3
R18	isAssociatedWith	Arg1:T5	Arg2:T4
